Hongchang PE Ratio 2013-2025 | HCIL
Current and historical p/e ratio for Hongchang (HCIL) from 2013 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Hongchang PE ratio as of September 18, 2026 is 0.00.
| Hongchang PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-09-16 | 0.11 | 177.83 | |
| 2025-12-31 | 0.14 | $0.00 | 0.00 |
| 2025-09-30 | 0.08 | 0 | 0.00 |
| 2025-06-30 | 0.00 | 0 | 0.00 |
| 2025-03-31 | 0.17 | 0 | 0.00 |
| 2024-12-31 | 0.10 | 0 | 0.00 |
| 2024-09-30 | 0.27 | 0 | 0.00 |
| 2024-06-30 | 0.20 | 0 | 0.00 |
| 2024-03-31 | 0.22 | 0 | 0.00 |
| 2023-12-31 | 0.35 | 0 | 0.00 |
| 2023-09-30 | 0.50 | 0 | 0.00 |
| 2023-06-30 | 1.78 | $0.00 | 0.00 |
| 2023-03-31 | 0.59 | $0.00 | 0.00 |
| 2022-12-31 | 0.01 | $0.00 | 0.00 |
| 2022-09-30 | 0.01 | $0.00 | 0.00 |
| 2022-06-30 | 0.10 | 0 | 0.00 |
| 2022-03-31 | 0.00 | 0 | 0.00 |
| 2021-12-31 | 0.00 | 0 | 0.00 |
| 2021-09-30 | 0.03 | 0 | 0.00 |
| 2021-06-30 | 0.17 | 0 | 0.00 |
| 2021-03-31 | 0.14 | 0 | 0.00 |
| 2020-12-31 | 0.12 | 0 | 0.00 |
| 2020-09-30 | 0.17 | 0 | 0.00 |
| 2020-06-30 | 0.07 | 0 | 0.00 |
| 2020-03-31 | 0.02 | 0 | 0.00 |
| 2019-12-31 | 0.05 | 0 | 0.00 |
| 2019-09-30 | 0.07 | 0 | 0.00 |
| 2019-06-30 | 0.10 | 0 | 0.00 |
| 2019-03-31 | 0.21 | 0 | 0.00 |
| 2018-12-31 | 0.12 | 0 | 0.00 |
| 2018-09-30 | 0.60 | 0 | 0.00 |
| 2018-06-30 | 0.32 | 0 | 0.00 |
| 2018-03-31 | 0.25 | 0 | 0.00 |
| 2017-12-31 | 0.74 | 0 | 0.00 |
| 2017-09-30 | 0.21 | 0 | 0.00 |
| 2017-06-30 | 0.20 | 0 | 0.00 |
| 2017-03-31 | 0.27 | 0 | 0.00 |
| 2016-12-31 | 0.47 | 0 | 0.00 |
| 2016-09-30 | 0.05 | 0 | 0.00 |
| 2016-06-30 | 0.03 | 0 | 0.00 |
| 2016-03-31 | 0.07 | 0 | 0.00 |
| 2015-12-31 | 0.37 | 0 | 0.00 |
| 2015-06-30 | 0.60 | $0.45 | 1.33 |
| 2015-03-31 | 1.25 | $0.45 | 2.76 |
| 2014-12-31 | 0.96 | $0.45 | 2.10 |
| 2014-09-30 | 0.79 | $0.45 | 1.74 |
| 2014-06-30 | 0.79 | 0 | 0.00 |
| 2014-03-31 | 0.93 | 0 | 0.00 |
| 2013-12-31 | 0.78 | 0 | 0.00 |
| 2013-06-30 | 1.26 | 0 | 0.00 |
| 2013-03-31 | 0.65 | 0 | 0.00 |
| 2012-09-30 | 0.46 | $0.91 | 0.51 |
| 2012-06-30 | 0.74 | $1.36 | 0.54 |
| 2010-09-30 | 6.26 | $5.00 | 1.25 |
| 2010-06-30 | 5.11 | $5.91 | 0.86 |
| 2010-03-31 | 5.80 | $5.00 | 1.16 |
| 2009-12-31 | 3.29 | $5.00 | 0.66 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.055B | $0.003B |
| Hongchang International Co Ltd is a holding company mainly engaged in research and development and manufacture a medical product. Hongchang International Co Ltd, formerly known as Heyu Biological Technology Corp, is based in China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $176.897B | 19.43 |
| Medtronic (MDT) | Ireland | $118.666B | 16.22 |
| Stryker (SYK) | United States | $107.450B | 20.08 |
| EssilorLuxottica (ESLOY) | France | $75.078B | 0.00 |
| Boston Scientific (BSX) | United States | $63.114B | 13.57 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.379B | 0.00 |
| Agilent Technologies (A) | United States | $44.077B | 25.80 |
| Medline (MDLN) | United States | $42.228B | 0.00 |
| ResMed (RMD) | United States | $32.950B | 20.45 |
| GE HealthCare Technologies (GEHC) | United States | $29.109B | 13.92 |
| Koninklijke Philips (PHG) | Netherlands | $24.258B | 12.92 |
| Terumo (TRUMY) | Japan | $21.654B | 20.68 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.977B | 11.11 |
| Baxter (BAX) | United States | $11.901B | 11.23 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.666B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.225B | 41.21 |
| Demant (WILYY) | Denmark | $10.101B | 0.00 |
| Insulet (PODD) | United States | $9.817B | 24.11 |
| Sunny Optical Technology (SNPTF) | China | $9.508B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.579B | 20.24 |
| BillionToOne (BLLN) | United States | $5.222B | 158.10 |
| Raia Drogasil SA - (RADLY) | Brazil | $5.122B | 0.00 |
| Haemonetics (HAE) | United States | $4.895B | 21.48 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| ICU Medical (ICUI) | United States | $3.822B | 22.82 |
| Envista Holdings (NVST) | United States | $3.805B | 16.12 |
| AtriCure (ATRC) | United States | $3.007B | 257.04 |
| Neogen (NEOG) | United States | $2.798B | 49.35 |
| Curaleaf Holdings (CURLF) | United States | $2.396B | 0.00 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.288B | 0.00 |
| Trulieve Cannabis (TRLV) | United States | $2.243B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.201B | 10.51 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.888B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.871B | 5.39 |
| LeMaitre Vascular (LMAT) | United States | $1.817B | 29.22 |
| BioLife Solutions (BLFS) | United States | $1.803B | 230.31 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.450B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.436B | 15.31 |
| Phibro Animal Health (PAHC) | United States | $1.399B | 10.73 |
| Omeros (OMER) | United States | $1.336B | 6.76 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.107B | 0.00 |
| CeriBell (CBLL) | United States | $0.959B | 0.00 |
| InMode (INMD) | Israel | $0.836B | 11.63 |
| AdaptHealth (AHCO) | United States | $0.785B | 16.46 |
| VAREX IMAGING (VREX) | United States | $0.781B | 17.17 |
| QuidelOrtho (QDEL) | United States | $0.761B | 8.21 |
| Glass House Brands (GLAS) | United States | $0.749B | 0.00 |
| Valneva SE (VALN) | France | $0.623B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.548B | 0.00 |
| Brainsway (BWAY) | Israel | $0.544B | 30.75 |
| Vireo Growth (VREOF) | United States | $0.540B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.537B | 0.00 |
| Cerus (CERS) | United States | $0.536B | 0.00 |
| Evolus (EOLS) | United States | $0.529B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.446B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.367B | 0.00 |
| SNDL (SNDL) | Canada | $0.350B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.341B | 24.86 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.302B | 0.00 |
| MacroGenics (MGNX) | United States | $0.263B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 13.28 |
| OraSure Technologies (OSUR) | United States | $0.241B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.236B | 22.62 |
| High Tide (HITI) | Canada | $0.236B | 53.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.201B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.191B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.151B | 0.00 |
| Quanterix (QTRX) | United States | $0.148B | 0.00 |
| Apyx Medical (APYX) | United States | $0.128B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.091B | 124.75 |
| FitLife Brands (FTLF) | United States | $0.090B | 11.77 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Accendra Health (ACH) | United States | $0.079B | 4.48 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Biote (BTMD) | United States | $0.049B | 3.97 |
| Nephros (NEPH) | United States | $0.046B | 38.46 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.036B | 17.21 |
| United-Guardian (UG) | United States | $0.033B | 13.39 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.023B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.018B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |